Palisade Bio Relocates Principal Offices
Ticker: PALI · Form: 8-K · Filed: Apr 5, 2024 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Apr 5, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $12.7895 |
| Sentiment | neutral |
Sentiment: neutral
Topics: administrative, office-move
TL;DR
PALISADE BIO moved offices effective April 2nd. New address: 7750 El Camino Real, Suite 2A, Carlsbad, CA 92009.
AI Summary
Palisade Bio, Inc. filed an 8-K on April 5, 2024, reporting a change in its principal executive offices to 7750 El Camino Real, Suite 2A, Carlsbad, California, 92009, effective April 2, 2024. This filing also includes amendments to its articles of incorporation or bylaws and other events, along with financial statements and exhibits.
Why It Matters
A change in principal executive offices can indicate operational shifts or consolidation for the company.
Risk Assessment
Risk Level: low — This filing primarily concerns a change in the company's physical address, which is a routine administrative event.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- 7750 El Camino Real, Suite 2A, Carlsbad, California, 92009 (location) — New Principal Executive Offices
- April 5, 2024 (date) — Filing Date
- April 2, 2024 (date) — Effective Date of Office Change
FAQ
What is the new address for Palisade Bio's principal executive offices?
The new address for Palisade Bio's principal executive offices is 7750 El Camino Real, Suite 2A, Carlsbad, California, 92009.
When did the change in principal executive offices become effective?
The change in principal executive offices became effective on April 2, 2024.
What is the filing date of this 8-K report?
This 8-K report was filed on April 5, 2024.
What are the main items reported in this 8-K filing?
This 8-K filing reports amendments to articles of incorporation or bylaws, other events (specifically the change in principal executive offices), and financial statements and exhibits.
What was Palisade Bio's former company name?
Palisade Bio, Inc. was formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc.
Filing Stats: 970 words · 4 min read · ~3 pages · Grade level 10.3 · Accepted 2024-04-05 16:30:30
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
- $12.7895 — $0.01 per share with a stated value of $12.7895 per share (the "Series A Preferred Stoc
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex3-1.htm (EX-3.1) — 15KB
- ex99-01.htm (EX-99.01) — 13KB
- ex99-01_001.jpg (GRAPHIC) — 2KB
- 0001493152-24-013336.txt ( ) — 254KB
- pali-20240405.xsd (EX-101.SCH) — 3KB
- pali-20240405_lab.xml (EX-101.LAB) — 33KB
- pali-20240405_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 5, 2024 Palisade Bio, Inc. /s/ J.D. Finley By: J.D. Finley Chief Executive Officer